Department of Cardiovascular Surgery, University Heart Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Department of Cardiovascular Surgery, University Heart Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Ann Thorac Surg. 2018 Aug;106(2):498-504. doi: 10.1016/j.athoracsur.2018.03.012. Epub 2018 Apr 11.
The study sought to report our results of surgical treatment of native and prosthetic aortic infection with xenopericardial tube grafts from the ascending aorta to beyond the bifurcation.
Within a 28-month period, 20 patients were treated with a bovine self-made pericardial tube graft to replace infected vascular grafts (after conventional surgical aortic replacement or endovascular stent graft implantation) or to treat a contaminated surgical site. An integrated standardized therapeutic concept was applied in all patients, consisting of complete removal of the infected prosthetic material, extensive debridement, and orthotopic vascular reconstruction with self-made tube grafts constructed from a bovine pericardial patch.
Four patients died perioperatively (20%) due to sepsis, pulmonary failure, or sudden circulatory arrest. The mean follow-up was 18 months (first quartile 2, third quartile 17 months). Interval computed tomography scans revealed 100% freedom from proven aortic reinfection, but reinfection cannot be ruled out in 4 patients who died of unknown causes during follow-up or because of ongoing sepsis. Three patients required aortic reintervention for a suture-line aneurysm, for graft occlusion, and for the development of a neoaortointestinal fistulation, respectively.
Patients with infectious aortic disease present in a frail state and the initial and the late mortality is substantial. Yet, surgical treatment of native and prosthetic aortic infection with xenopericardial tube grafts shows promising short-term results with regard to durability and freedom from reinfection in any aortic segment. Further studies are needed to learn of the long-term behavior of these grafts.
本研究旨在报告我们使用牛心包管移植物从升主动脉至分叉处以外治疗原发和人工主动脉感染的手术治疗结果。
在 28 个月的时间内,20 例患者接受了牛自制心包管移植物治疗,以替换感染的血管移植物(在常规外科主动脉置换或血管内支架移植术后)或治疗受污染的手术部位。所有患者均采用综合标准化治疗方案,包括彻底清除感染的人工材料、广泛清创以及使用牛心包补片构建的自制管状移植物进行原位血管重建。
4 例患者(20%)在围手术期因败血症、肺衰竭或心脏骤停死亡。平均随访时间为 18 个月(第一四分位数 2,第三四分位数 17 个月)。间隔 CT 扫描显示,100%的患者无明确的主动脉再感染,但在随访期间死于不明原因或持续败血症的 4 例患者中不能排除再感染。3 例患者分别因缝线动脉瘤、移植物闭塞和新发主动脉肠瘘而行主动脉再次介入治疗。
患有感染性主动脉疾病的患者身体虚弱,初始和晚期死亡率很高。然而,使用异种心包管移植物治疗原发和人工主动脉感染的手术治疗在任何主动脉节段的耐久性和无再感染方面显示出良好的短期结果。需要进一步研究了解这些移植物的长期行为。